• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

2D-SAR, Topomer CoMFA and molecular docking studies on avian influenza neuraminidase inhibitors

tetano

Editor, Senior Moderator
Comput Struct Biotechnol J. 2018 Dec 7;17:39-48. doi: 10.1016/j.csbj.2018.11.007. eCollection 2019.
[h=1]2D-SAR, Topomer CoMFA and molecular docking studies on avian influenza neuraminidase inhibitors.[/h] Niu B[SUP]1[/SUP], Lu Y[SUP]1[/SUP], Wang J[SUP]1[/SUP], Hu Y[SUP]1[/SUP], Chen J[SUP]1[/SUP], Chen Q[SUP]1[/SUP], He G[SUP]2[/SUP], Zheng L[SUP]3,[/SUP][SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Avian influenza is a serious zoonotic infectious disease with huge negative impacts on local poultry farming, human health and social stability. Therefore, the design of new compounds against avian influenza has been the focus in this field. In this study, computational methods were applied to investigate the compounds with neuraminidase inhibitory activity. First, 2D-SAR model was built to recognize neuraminidase inhibitors (NAIs). As a result, the accuracy of 10 cross-validation and independent tests is 96.84% and 98.97%, respectively. Then, the Topomer CoMFA model was constructed to predict the inhibitory activity and analyses molecular fields. Two models were obtained by changing the cutting methods. The second model is employed to predict the activity (q[SUP]2[/SUP] = 0.784 and r[SUP]2[/SUP] = 0.982). Molecular docking was also used to further analyze the binding sites between NAIs and neuraminidase from human and avian virus. As a result, it is found that same binding Total Score has some differences, but the binding sites are basically the same. At last, some potential NAIs were screened and some optimal opinions were taken. It is expected that our study can assist to study and develop new types of NAIs.


[h=4]KEYWORDS:[/h] 2D-SAR; Avian influenza; Molecular docking; Neuraminidase; Topomer CoMFA

PMID: 30595814 PMCID: PMC6305694 DOI: 10.1016/j.csbj.2018.11.007
 
Back
Top Bottom